Patrick McLeroth

Learn More
Objectives The β-lactamase inhibitor relebactam can restore imipenem activity against imipenem non-susceptible pathogens. Methods To explore relebactam's safety, tolerability and efficacy, we(More)
Background Our objective in this study was to demonstrate the safety and efficacy of iclaprim compared with vancomycin for the treatment of patients with acute bacterial skin and skin structure(More)
  • 1